Therefore, our findings about the role of MRTF‐A in muscle regeneration raises the possibility of therapeutic strategies that inhibition of MRTF‐A in myoblast, whether by dominant‐negative expression or antagonist treatment, will benefit patients with muscular disorders. This evidence concerns the gene MRTFA and muscle tissue disorder.